Personalized Vaccines and Beyond: Confronting the Complex Biology of Kidney Cancer
A promising new personalized vaccine headlines several recent breakthroughs that highlight progress in kidney cancer research.
Tag: CAR T-cell therapy
A promising new personalized vaccine headlines several recent breakthroughs that highlight progress in kidney cancer research.
Multiple myeloma can be tricky to treat, but many treatment options exist, and new research is constantly supporting more.
The third keynote session at AACR IO highlighted exciting advances in CAR T-cell therapy, including for solid cancers.
This month, the editors of AACR's journals show their love for studies about CAR T-cell efficacy, breast cancer risk,...
Amidst an FDA investigation into secondary cancers after CAR T therapy, researchers show the risk is likely minimal.
The AACR journal editors' picks for July 2024 include a review of the risks from CAR T-cell therapy, advances...
The FDA issued 18 oncology-related approvals in Q2 2024 including two first-in-class drugs and a bispecific T-cell engager for...
As the spring weather encourages the planting of flowers, vegetables, and herbs, even careful gardeners may see weeds creeping...
For the sixth time since 2015, researchers, clinicians, drug developers, patient advocates, and other stakeholders convened at the International...
Immunotherapy has revolutionized cancer treatment over the past decade, providing potentially lifesaving therapies to many patients who otherwise would have limited options. Despite its success...